Clinical Research

Researchers use multi-modality imaging to learn more about MINOCA
The combination of OCT and MRI can help provide an improved sense of clarity when managing MINOCA patients, according to new data presented at ACC.26 in New Orleans.
Evolocumab reduces risk of major cardiac events in diabetic patients
Late-breaking data out of ACC.26 suggest a more aggressive treatment approach for these patients could be beneficial.
Heart Rhythm 2026 to feature late-breaking EP data, hands-on training and more
Heart Rhythm 2026 in Chicago will include a total of 18 late-breaking clinical trials—and that is just the beginning. The four-day event kicks off April 23.
Late-breaking PCI data challenge the 'time is muscle' paradigm
Gregg Stone, MD, spoke to Cardiovascular Business about the lessons he and his colleagues learned from the STEMI DTU trial.
Early SAVR in asymptomatic heart patients linked to long-term benefits
New 10-year data explored the impact of performing SAVR on asymptomatic patients with severe aortic stenosis.

ACC 2023 ACC.23 American College of Cardiology

American College of Cardiology announces late-breaking research for ACC.24 in Atlanta

The group's annual meeting heads to Atlanta this April. TAVR, GLP-1 agonists, medical imaging guidance and blood pressure control are just some of the topics that will be presented during late-breaking sessions.

Mutations in three-dimensional structures of the genome may be a cause of autism

The study involved an analysis of the genomic data from 5,000 families and could lead to new treatments.

Researchers simulate red blood cells, oxygen flow using low-frequency ultrasound

Scientists from Lithuania said the therapy could be helpful for patients struggling with lung damage from COVID-19.

Isotope used in cancer drug development shipped for clinical trials

Actinium-225 remains in short supply, slowing drug research.

Premature births can be predicted at 23 weeks using ultrasound

The method was developed based on 22 years of research and has been shown effective in a new study.

UVA Health receives $3.1M grant for using ultrasound to deliver drugs into the brain

Researchers are aiming to use ultrasound to breach the blood-brain barrier and deliver drug therapies.

Samin Sharma, MD, director of interventional cardiology and director of clinical cardiology, Mount Sinai Hospital, New York, discusses the first-in-human use of the Magenta Elevate percutaneous left ventricular assist device (pLVAD) with a small 10 French size and 5.5 liters per minute of hemodynamic support.

Initial results promising for world's smallest percutaneous heart pump

A new 10 French percutaneous heart pump could help greatly reduce vascular complications and improve cardiogenic shock outcomes.

Pre-clinical images of the Abbott Volt pulsed field ablation system creating lesions using electroporation, presented at the 2023 AHA Scientific Sessions, The Abbott PFA system is now being used in a first-in-human study at the Centre for Heart Rhythm Disorders at the University of Adelaide, Australia.

First patients treated with Abbott’s pulsed field ablation offering

According to Abbott, its Volt system was specifically designed to address weaknesses seen in other first-generation PFA offerings.

Clinical Research

Researchers use multi-modality imaging to learn more about MINOCA

Evolocumab reduces risk of major cardiac events in diabetic patients

Heart Rhythm 2026 to feature late-breaking EP data, hands-on training and more

Late-breaking PCI data challenge the 'time is muscle' paradigm

Early SAVR in asymptomatic heart patients linked to long-term benefits

Evolocumab reduces risk of major cardiac events in diabetic patients